Long-term efficacy and safety of perampanel in patients aged 60 years and older with focal seizures: Post hoc analysis of phase III open-label extension studies stratified by enzyme-inducing anti-seizure medication use. [PDF]
Marawar R +4 more
europepmc +1 more source
Comparison of the effectiveness, safety and tolerability of Perampanel and Levetiracetam as monotherapy in Chinese patients with focal-onset seizures: A single-center, ambispective, open-label, real-world observational study. [PDF]
Ma H +9 more
europepmc +1 more source
Safety and Efficacy of the AMPA Receptor Antagonist Perampanel for Tremors: A Systematic Review. [PDF]
Manalo RVM, Dela Cruz JRC, Pasco PM.
europepmc +1 more source
A case report of seizure worsening after perampanel add-on to oxcarbazepine: possible role of metabolic interaction and pharmacogenetics. [PDF]
Fang X, Zhu M, Wang L.
europepmc +1 more source
Effectiveness of perampanel as the only adjunctive anti-seizure medication in adults: Final results from the observational PERPRISE study in Germany. [PDF]
Steinhoff BJ +3 more
europepmc +1 more source
Single-Dose Intraoperative Perampanel Infusion During Awake Glioma Surgery for Potential Prophylaxis of Intraoperative and Early Postoperative Seizures: A Case Report and Literature Review. [PDF]
Tamura G +4 more
europepmc +1 more source
Emptying the fridge syndrome: a case of nocturnal food craving associated with peak perampanel concentration. [PDF]
Vassallo P, Sander JW.
europepmc +1 more source
Drug-resistant Epilepsy: Which Drugs are Substrates of P-glycoprotein and Which are Not? [PDF]
Aylón Val J, Hernando-Requejo V.
europepmc +1 more source
Perampanel for alleviation of secondary injury in traumatic brain injury (PEACE-TBI): a protocol for a phase-II multicentre randomised clinical trial. [PDF]
Yamamoto R +23 more
europepmc +1 more source
Perampanel-associated exacerbation of de novo psychosis and lateralized rhythmic delta activity: A case report. [PDF]
Fujiwara Y +4 more
europepmc +1 more source

